A673 Cells
USD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The A673 cell line is a valuable resource in biological science. Derived from the muscle tissue of a 15-year-old female patient diagnosed with Ewings Sarcoma, this cell line exhibits a distinct polygonal morphology. Originally the cell line was thought to be derived from a rhabdomyosarcoma (RMS). One of the remarkable characteristics of A673 cells is their ability to produce several growth factors that possess oncogenic potential. These cells also secrete growth-inhibitory factors, providing a balanced environment for cellular growth regulation. Such properties make A673 cells an excellent model for investigating the interplay between tumour-promoting and tumour-suppressing factors. A673 cells have demonstrated tumorigenic potential, as they can induce tumour formation in immunosuppressed mice. Moreover, studies have identified hypermethylated promoters in cancer-related genes within the A673 cell line. These genetic alterations further contribute to its relevance in cancer research, offering a platform to explore epigenetic modifications and their impact on tumour development and progression. While A673 cells are often referred to as Ewing tumour (ET) or sarcoma (ES), they are also associated with rhabdomyosarcoma (RMS). Notably, the A673 cell line harbours a complex karyotype with a specific translocation involving chromosomes 11 and 22. This translocation leads to the fusion of the EWS and FLI1 genes, which is a characteristic genetic event in Ewing Tumor. |
|---|---|
| Organism | Human |
| Tissue | Bone |
| Disease | Ewing's Sarcoma |
| Synonyms | A-673, RMS 1598, RMS1598 |
Characteristics
| Age | 15 years |
|---|---|
| Gender | Female |
| Ethnicity | Caucasian |
| Morphology | Fibroblast-like |
| Growth properties | Monolayer, adherent |
Regulatory Data
| Citation | A673 (Cytion catalog number 300454) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_0080 |
Biomolecular Data
| Tumorigenic | Yes, in immunosuppressed mice |
|---|---|
| Virus susceptibility | Highly sensitive to human adenoviruses |
Handling
| Culture Medium | DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Doubling time | 28 hours |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 1 x 104 cells/cm2 will result in a confluent monolayer within 8 days. |
| Fluid renewal | 2 to 3 times per week |
| Post-Thaw Recovery | After thawing, plate the cells at 5 x 104 cells/cm2 and allow the cells to recover from the freezing process and to adhere for at least 24 hours. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300454-3d21 | Certificate of Analysis | 26. May. 2025 | 300454 |